期刊文献+

血管性血友病因子前肽双抗体夹心法检测及临床应用 被引量:4

Development and clinical application of vWF-pp ELISA Kit
原文传递
导出
摘要 目的建立血浆血管性假血友病因子前肽(vWFpp)的测定方法,并检测152例健康体检者及36例冠心病患者和38例同龄正常对照组的血浆vWFpp水平。方法采用酶联免疫吸附分析(ELISA)双抗体夹心法对152例体检者和36例冠心病患者血浆vWFpp进行测定。结果152例体检者vWFpp水平为496.44±167.24μg/L。50~60岁年龄组vWFpp显著高于40岁以下年龄组(P<0.01)。男女间vWFpp水平差异无统计学意义(P>0.05)。男51~60岁年龄组与16~20,21~30,31~40岁的3个年龄组vWFpp水平差异都具有显著的统计学意义(P<0.05);152份体检者血浆样品vWFpp水平与年龄的相关性分析显示,vWFpp水平与年龄呈显著的正相关关系(r=0.444,P=0.000)。冠心病组vWFpp水平为1051.6±331.9μg/L,与同年龄段对照组vWFpp水平485.2±119.4μg/L比较具有显著性差异(P<0.001)。结论该法测定血浆vWFpp具有特异、快速、灵敏的优点,具有良好的临床应用前景。 Objective To establish a sandwich enzyme linked immunosorbent assay (ELISA) method for determination of von Willebrand factor propeptide (vWF-pp) in plasma and to determine thelevels of plasma vWF-pp in 152 healthy volunteers, 36 patients with coronary heart disease and 38 cases ofthe normal control group with the same ages. Methods The levels of vWF-pp in 152 healthy volunteers withdifferent ages and different genders and in 36 patients with coronary heart disease were determined with thesandwich enzyme linked immuno-sorbent assay (ELISA). Results The average level of vWF-pp in 152healthy volunteers was 496.4±167. 2μg/L. The level of vWF-pp in the 50- 60 years old group wassignificantly higher than that in the less than 40 years old group ( P 〈 0. 05 ). There was no significantdifferece between male and female (P 〉 0. 05 ). There was significant difference between the 51-60 years old male group and the other three male groups respectively, the 16 ~20 years old group, the 21 -30 yearsold group and the 31 ~ 40 years old group (P 〈 0. 05 ) . There was the significant positive correlation betweenthe level of vWF-pp in 152 healthy volunteers and the age with r = 0. 444 and P = 0. 000. There wassignificant difference in the level of vWF-pp between the coronary heart disease groups ( 1051.6±331.9 )μg/L) and the health groups (485.15±119.4)μg/L with the same ages. Conchmion The sandwichenzyme linked immunosorbent assay (ELISA) method is specific, rapid and sensitive in the determination ofthe plasma vWF-pp with a good perspective of the clinical application.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2006年第3期226-228,共3页 Chinese Journal of Laboratory Medicine
关键词 von Willebrand病 酶联免疫吸附测定 yon Willebrand disease Enzyme-linked immunosorbent assay
  • 相关文献

参考文献7

  • 1van Mourik JA,Romani de Wit T.Von Willebrand factor propeptide in vascular disorders.Thromb Haemost,2001,86:164-171. 被引量:1
  • 2朱忠勇.实用医学检验学[M].北京:人民军医出版社,1998.1084. 被引量:27
  • 3Haberichter SL,Fahs SA,Montgomery RR.Von willebrand factor storage and multimerrization:2 independent intracellular processes.Blood,2000,96:1808-1815. 被引量:1
  • 4Wiman B,Andersson T,Hallqvist J,et al.Plasma levels of tissue plasminogen activator/plasminogen activator inhihitor-1 complex and von Willehrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) Study.Arterioscler Thromb Vasc Biol,2000,20:2019-2023. 被引量:1
  • 5Thalia Romani de Wit,Jan A.van Mourik.General Introduction.Clinical Haemtology,2001,14:241-256. 被引量:1
  • 6Romani De Wit T,Fijnheer R,Brinkman HJ,et al.Endothelial cell activation in thrombotic thrombocytopenic purpura (TTP):a prospective analysis.Br J Haematol,2003,123:522-527. 被引量:1
  • 7Verrotti A,Greco R,Basciani F,et al.von Willebrand factor and its propeptide in children with diabetes.Relation between endothelial dysfunction and microalbuminuria.Pediatr Res,2003,53:382-386. 被引量:1

共引文献26

同被引文献34

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部